Venture(US:VEMLY) 智通财经网·2025-12-30 11:33Core Viewpoint - Jiangsu Qingquan Chemical Co., Ltd. has received acceptance for its IPO on the Shenzhen Stock Exchange's ChiNext board, aiming to raise approximately 492.3 million yuan [1] Company Overview - Qingquan Chemical specializes in the R&D, production, and sales of specialty fine chemicals and high-performance polymer materials, recognized as a national-level "little giant" enterprise focusing on specialized and innovative sectors [1] - The company has developed a product system that includes new material monomers, green solvents, pharmaceutical and pesticide intermediates, and specialty polymer materials, with applications in various industries such as aerospace, wind power, automotive, electronics, medical devices, chemicals, pharmaceuticals, and pesticides [1] Market Position - The company's core products, including the new material monomer MACM and the green solvent 2-MeTHF, have achieved high industry standards and are competitive against major industry players [1] - According to reports, Qingquan Chemical is projected to hold approximately 28% of the global market share for MACM and about 19% for 2-MeTHF in 2024 [1] Fundraising and Investment Plans - The funds raised from the IPO will be allocated to projects related to the company's main business, including: - A technical transformation project for producing 5,000 tons of MACM - A technical transformation project for producing 4,000 tons of THF - Construction of a research and development center - Supplementing working capital [2][3] Financial Performance - The company's revenue for the years 2022, 2023, 2024, and the first half of 2025 is projected to be approximately 687 million yuan, 713 million yuan, 797 million yuan, and 396 million yuan respectively, with net profits of 52.83 million yuan, 81.82 million yuan, 98.66 million yuan, and 57.91 million yuan [3] - As of June 30, 2025, total assets are expected to be around 1.023786 billion yuan, with equity attributable to shareholders of the parent company at approximately 706.95 million yuan [4] - The company has shown a decreasing asset-liability ratio from 44.03% in 2022 to an expected 24.63% in 2025, indicating improved financial stability [4]